US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 27.400
  • -0.060-0.22%
Close Feb 14 16:00 ET
  • 27.400
  • 0.0000.00%
Post 17:01 ET
3.41BMarket Cap-13.50P/E (TTM)

Apellis Pharmaceuticals Key Stats

Apellis Pharmaceuticals Q4 2024 Estimates Date

Currency:USDFeb 28, 2025

Estimate YoY
Revenue
197.92M
+35.21%
EPS
-0.39
+46.23%
Buy

Feb 16, 2025

Apellis Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 198.646M--
Feb 28, 20252024/Q4-- / 197.915M--
Nov 5, 20242024/Q3196.830M / 199.824M--
Aug 1, 20242024/Q2199.685M / 191.306M--
May 7, 20242024/Q1172.325M / 164.259M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 198.646M--
Feb 28, 20252024/Q4-- / 197.915M--
Nov 5, 20242024/Q3196.830M / 199.824M--
Aug 1, 20242024/Q2199.685M / 191.306M--
May 7, 20242024/Q1172.325M / 164.259M--

Unlock Free Earnings Estimates

Apellis Pharmaceuticals Earnings Reports

Read more

Trending Stocks

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More